Worldwide market for biosimilars at its tipping point

Worldwide growth in the biosimilars market is hitting its tipping point, analysts say. Sales are projected to hit $25 billion by 2020, according to the folks over at BioWorld who put together a new report, “Biosimilars: A Global Perspective of a New Market.” This is pretty impressive projected growth, considering that total global sales of drugs approved […]